July 8, 2016
Vernalis completes its CCP-08 pivotal bioavailability studies
Vernalis has today announced the completion of the CCP-08 pivotal multiple-dose comparative bioavailability study.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Ian Garland
October 2, 2015
Vernalis Acquires U.S. Rights to Moxatag
Vernalis plc has announces that it has acquired the US rights to Moxatag (amoxicillin extended-release tablets) from Pragma Pharmaceuticals, LLC (“Pragma”).